Catyalyst Pharmaceutical (CPRX) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.45 +0.03%
Revenue Growth %: +6.2%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
CRMT, More
Revenue Growth %: +6.2%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Catyalyst Pharmaceutical (NASDAQ: CPRX) reported Q4 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
